Rating Change
Citizens reiterated its Market Outperform rating on OptimizeRx Corporation (NASDAQ:OPRX) on August 14, 2026.
reiterateNASDAQ:OPRX
Citizens Reiterates Market Outperform Rating on OptimizeRx Corporation (OPRX)
Citizens reiterated its Market Outperform rating on OptimizeRx Corporation (NASDAQ:OPRX) on August 14, 2026.
At publication ·
What changed
OptimizeRx Corporation (NASDAQ:OPRX) · reiterate
- Firm
- Citizens
- Rating
- Market Outperform to Market Outperform
- Price at event
- $8.83
- Market capitalization
- $259.7M
At a glance
Key takeaways
- Citizens reiterated a Market Outperform rating on OptimizeRx Corporation (NASDAQ:OPRX) on August 14, 2026, with the stock trading at $8.83 and a market capitalization of $259.7 million.
Market Context
OptimizeRx Corporation operates in the Healthcare sector. The stock currently trades at $8.83 with a market capitalization of $259.7M.
Analyst coverage from Citizens provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for OptimizeRx Corporation.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for OptimizeRx Corporation
Among the 10 most recent ratings: 8 Buy, 2 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 14, 2026 | Citizens | Market Outperform | N/A |
| May 13, 2026 | Lake Street | Buy | N/A |
| May 13, 2026 | Stephens & Co. | Equal-Weight | N/A |
| May 13, 2026 | B. Riley Securities | Buy | N/A |
| May 13, 2026 | Stifel | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View OPRX Stock Page
Frequently Asked Questions
What does the Market Outperform rating mean for OPRX?
A rating of Market Outperform from Citizens reflects the analyst's outlook on OptimizeRx Corporation (NASDAQ:OPRX). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the OPRX forecast page.